Literature DB >> 24683014

Radiological imaging in ataxia telangiectasia: a review.

Ishani Sahama1, Kate Sinclair, Kerstin Pannek, Martin Lavin, Stephen Rose.   

Abstract

The human genetic disorder ataxia telangiectasia (A-T) is characterised by neurodegeneration, immunodeficiency, radiosensitivity, cell cycle checkpoint defects, genomic instability and cancer predisposition. Progressive cerebellar ataxia represents the most debilitating aspect of this disorder. At present, there is no therapy available to cure or prevent the progressive symptoms of A-T. While it is possible to alleviate some of the symptoms associated with immunodeficiency and deficient lung function, neither the predisposition to cancer nor the progressive neurodegeneration can be prevented. Significant effort has focused on improving our understanding of various clinical, genetic and immunological aspects of A-T; however, little attention has been directed towards identifying altered brain structure and function using MRI. To date, most imaging studies have reported radiological anomalies in A-T. This review outlines the clinical and biological features of A-T along with known radiological imaging anomalies. In addition, we briefly discuss the advent of high-resolution MRI in conjunction with diffusion-weighted imaging, which enables improved investigation of the microstructural tissue environment, giving insight into the loss in integrity of motor networks due to abnormal neurodevelopmental or progressive neurodegenerative processes. Such imaging approaches have yet to be applied in the study of A-T and could provide important new information regarding the relationship between mutation of the ataxia telangiectasia mutated (ATM) gene and the integrity of motor circuitry.

Entities:  

Mesh:

Year:  2014        PMID: 24683014     DOI: 10.1007/s12311-014-0557-4

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  113 in total

1.  Abnormal white matter signal in ataxia telangiectasia.

Authors:  J J Ciemins; A L Horowitz
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

2.  Proton MR spectroscopic imaging in ataxia-telangiectasia.

Authors:  D D M Lin; T O Crawford; H M Lederman; P B Barker
Journal:  Neuropediatrics       Date:  2006-08       Impact factor: 1.947

3.  Cytoskeletal pathology in ataxia-telangiectasia.

Authors:  S Monaco; E Nardelli; G Moretto; T Cavallaro; N Rizzuto
Journal:  Clin Neuropathol       Date:  1988 Jan-Feb       Impact factor: 1.368

4.  Serum-alpha-fetoprotein levels in patients with ataxia-telangiectasia.

Authors:  T A Waldmann; K R McIntire
Journal:  Lancet       Date:  1972-11-25       Impact factor: 79.321

5.  A case of ataxia-telangiectasia with lesions in the spinal cord.

Authors:  P Sourander; J O Bonnevier; Y Olsson
Journal:  Acta Neurol Scand       Date:  1966       Impact factor: 3.209

6.  Protective roles for ATM in cellular response to oxidative stress.

Authors:  N Takao; Y Li; K Yamamoto
Journal:  FEBS Lett       Date:  2000-04-21       Impact factor: 4.124

7.  Ataxia-telangiectasia: MR and CT findings.

Authors:  L Farina; C Uggetti; A Ottolini; A Martelli; R Bergamaschi; L Sibilla; F Zappoli; M G Egitto; G Lanzi
Journal:  J Comput Assist Tomogr       Date:  1994 Sep-Oct       Impact factor: 1.826

Review 8.  Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress?

Authors:  G Rotman; Y Shiloh
Journal:  Bioessays       Date:  1997-10       Impact factor: 4.345

9.  Brain MRI abnormalities in ataxia-telangiectasia.

Authors:  Mario Habek; Vesna V Brinar; Marko Rados; Ivana Zadro; Kamelija Zarković
Journal:  Neurologist       Date:  2008-05       Impact factor: 1.398

10.  Cerebral white-matter changes suggesting leukodystrophy in ataxia telangiectasia.

Authors:  E O Chung; J B Bodensteiner; P A Noorani; S S Schochet
Journal:  J Child Neurol       Date:  1994-01       Impact factor: 1.987

View more
  11 in total

1.  A novel porcine model of ataxia telangiectasia reproduces neurological features and motor deficits of human disease.

Authors:  Rosanna Beraldi; Chun-Hung Chan; Christopher S Rogers; Attila D Kovács; David K Meyerholz; Constantin Trantzas; Allyn M Lambertz; Benjamin W Darbro; Krystal L Weber; Katherine A M White; Richard V Rheeden; Michael C Kruer; Brian A Dacken; Xiao-Jun Wang; Bryan T Davis; Judy A Rohret; Jason T Struzynski; Frank A Rohret; Jill M Weimer; David A Pearce
Journal:  Hum Mol Genet       Date:  2015-09-15       Impact factor: 6.150

Review 2.  Ataxia-telangiectasia - A historical review and a proposal for a new designation: ATM syndrome.

Authors:  Hélio A G Teive; Adriana Moro; Mariana Moscovich; Walter O Arruda; Renato P Munhoz; Salmo Raskin; Tetsuo Ashizawa
Journal:  J Neurol Sci       Date:  2015-05-29       Impact factor: 3.181

3.  A novel, ataxic mouse model of ataxia telangiectasia caused by a clinically relevant nonsense mutation.

Authors:  Harvey Perez; May F Abdallah; Jose I Chavira; Angelina S Norris; Martin T Egeland; Karen L Vo; Callan L Buechsenschuetz; Valentina Sanghez; Jeannie L Kim; Molly Pind; Kotoka Nakamura; Geoffrey G Hicks; Richard A Gatti; Joaquin Madrenas; Michelina Iacovino; Peter J McKinnon; Paul J Mathews
Journal:  Elife       Date:  2021-11-01       Impact factor: 8.713

Review 4.  Ataxia telangiectasia: a review.

Authors:  Cynthia Rothblum-Oviatt; Jennifer Wright; Maureen A Lefton-Greif; Sharon A McGrath-Morrow; Thomas O Crawford; Howard M Lederman
Journal:  Orphanet J Rare Dis       Date:  2016-11-25       Impact factor: 4.123

5.  Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasia.

Authors:  Katherine Schon; Nienke J H van Os; Nicholas Oscroft; Helen Baxendale; Daniel Scoffings; Julian Ray; Mohnish Suri; William P Whitehouse; Puja R Mehta; Natasha Everett; Leonardo Bottolo; Bart P van de Warrenburg; Philip J Byrd; Corry Weemaes; Michel A Willemsen; Marc Tischkowitz; A Malcolm Taylor; Anke E Hensiek
Journal:  Ann Neurol       Date:  2019-02       Impact factor: 10.422

Review 6.  Therapeutic roles of natural remedies in combating hereditary ataxia: A systematic review.

Authors:  Michael Weng Lok Phang; Sze Yuen Lew; Ivy Chung; William Kiong-Seng Lim; Lee Wei Lim; Kah Hui Wong
Journal:  Chin Med       Date:  2021-01-28       Impact factor: 5.455

7.  Loss of atm in Zebrafish as a Model of Ataxia-Telangiectasia Syndrome.

Authors:  Kehua Chen; Peng Wang; Jingrun Chen; Yiling Ying; Yi Chen; Eric Gilson; Yiming Lu; Jing Ye
Journal:  Biomedicines       Date:  2022-02-07

Review 8.  Consensus Recommendations for the Clinical Management of Hematological Malignancies in Patients with DNA Double Stranded Break Disorders.

Authors:  Agata Pastorczak; Andishe Attarbaschi; Simon Bomken; Arndt Borkhardt; Jutte van der Werff Ten Bosch; Sarah Elitzur; Andrew R Gennery; Eva Hlavackova; Arpád Kerekes; Zdenka Křenová; Wojciech Mlynarski; Tomasz Szczepanski; Tessa Wassenberg; Jan Loeffen
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

9.  Motor pathway degeneration in young ataxia telangiectasia patients: A diffusion tractography study.

Authors:  Ishani Sahama; Kate Sinclair; Simona Fiori; James Doecke; Kerstin Pannek; Lee Reid; Martin Lavin; Stephen Rose
Journal:  Neuroimage Clin       Date:  2015-08-20       Impact factor: 4.881

10.  Neurofilament Light Chain Is a Biomarker of Neurodegeneration in Ataxia Telangiectasia.

Authors:  H Donath; S Woelke; R Schubert; M Kieslich; M Theis; G Auburger; R P Duecker; S Zielen
Journal:  Cerebellum       Date:  2021-04-24       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.